Scar — Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2.
Citation(s)
Post-operative Topical Administration of Fibrosis Inhibiting Compound FS2 in a Double-blind, Randomized, Vehicle-controlled Study Evaluating the Safety and Prevention of Cutaneous Scarring in Skin Grafts and Donor Sites.